Purpose: To determine the potential use of water-soluble anionic and cationic carbosilane dendrimers (Generations 1-3) as mucoadhesive polymers in eyedrop formulations. Methods:
The methodology used to synthesize cationic dendrimers avoids the difficulty of obtaining neutral -NH 2 dendrimers that require harsher reaction conditions and also present high aggregation tendency. Tolerance studies demonstrated that both prototypes of water-soluble anionic and cationic carbosilane dendrimers were well tolerated in a range of concentrations between 5 and 10 µM. Permanent interactions between cationic carbosilane dendrimers and ocular mucins were observed using biosensor assays, predominantly for the generation-three (G3) dendrimer. An eyedrop formulation containing G3 cationic carbosilane dendrimers (5 µM) and ACZ (0.07%) (289.4 mOsm; 5.6 pH; 41.7 mN/m) induced a rapid (onset time 1 h) and extended (up to 7 h) hypotensive effect, and led to a significant increment in the efficacy 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 to improve the hypotensive effect of an acetazolamide solution. Our results suggest that carbosilane dendrimers can be used in a safe range of concentrations to enhance the bioavailability of drugs topically administered in the eye.
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Introduction
It is estimated that only about 5% of any drug administered by the topical ocular route is able to cross the cornea, reaching the anterior segment of the eye. 1 This makes it necessary to administer multiple doses of the drug per day. Furthermore, a portion of some administered drugs can be absorbed through the nasal and oral mucosa following drainage through the naso-lacrimal duct, and this can result in systemic side effects. One approach to increase ocular drug bioavailability is to maintain the formulation on the ocular surface longer. Classic (linear) bioadhesive polymers such as hyaluronic acid or cellulose derivatives included in eyedrop formulations can increase the drug residence time on the ocular surface.
With this strategy, both the systemic drug side effects and the dosing frequency can be reduced. 2, 3 However, discomfort, blurred vision, and the presence of residual material around the eye are typically associated to these viscous media.
Recently, the use of dendritic structures has been explored with the aim of increasing the residence time of drugs on the ocular surface and reducing systemic absorption. For example, several authors have shown that polyamidoamine (PAMAM) dendrimers in solution 4 or combined with polyethylene glycol as hydrogels 5 can improve the residence time of several drugs. These dendritic structures can strongly interact with transmembrane ocular mucins, as recently demonstrated by our research group. 6 The approach presented in this work uses new dendritic structures based on a C-Si backbone (carbosilane dendrimers) as potential bioadhesive polymers to be included in eyedrop formulations. These structures could benefit the administration of very poorly water-soluble drugs on the ocular surface.
However, the higher hydrophobicity of carbosilane dendrimers implies that it is necessary to introduce ionic moieties (anionic or cationic groups) to achieve solubility in water. [7] [8] [9] The objective of the present work is the evaluation of Generations 1, 2, and 3 of carbosilane dendrimers, with both anionic and cationic terminal groups, for topical ocular delivery. In an attempt to select the optimal concentration of these structures suitable for eye tissues, we first estimated the in vitro and in vivo tolerance in human 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 conjunctival and corneal cell lines and in rabbit eyes. Afterwards, the interaction of carbosilane dendrimers with transmembrane ocular mucin isolates was evaluated by surface plasmon resonance (SPR) spectroscopy. 6 The most promising candidate was formulated with acetazolamide (ACZ), a hypotensive drug useful in glaucoma treatment after oral administration but which is inadequate for topical application due to low bioavailability after instillation. The eyedrop formulation was characterized and tested in normotensive rabbits.
Materials and Methods
Materials
We prepared anionic dendrimers G n Si( 
Animals
Male New Zealand white rabbits (San Bernardo Farm, Navarra, Spain), weighing 3-3.5 kg, were used for some experiments. The animals were kept in individual cages with free access to food and water. They 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 were housed in a room with controlled 12h/12h light/dark cycles and maintained at 22ºC with 50% instruments. Starting dendrimers were G n O 3 (SiH) m (n = 1, m = 6; n = 2, m = 12; n = 3, m = 24) 10 .
The synthesis of cationic dendrimers is presented in Scheme 1. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Carbosilane dendrimers of Generations 1 to 3, both anionic and cationic, were dissolved in NaCl 0.9% media prior to characterization. For simplicity, the nomenclature employed for dendrimers described in the remainder of this paper will be of the type "Gn-A" (for anionic dendrimers) or "Gn-C" (for cationic dendrimers), where "Gn" indicates the generation.
Tolerance studies
In vitro experiments The cytotoxicity of saline solutions of C-Si anionic and cationic dendrimers G1-3
was assessed by the mitochondrial-dependent reduction of the tetrazolium salt (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) to formazan (MTT method) according to previous works. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Boston, MA, USA) and normal human conjunctiva (IOBA-NHC) cells generously donated by the The results were expressed as the reduction in cellular viability compared to negative controls for at least three independent experiments. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 membrane, and transparency of the cornea. 11 Ocular signs were graded using the Efron scale (0 = normal; 1 = trace; 2 = mild; 3 = moderate; 4 = severe) 12
In vivo experiments
Mucoadhesion studies
After the tolerance studies, the interaction of selected concentrations of C-Si anionic and cationic dendrimers G1-3 with transmembrane ocular mucins was analyzed by SPR spectroscopy (Biacore  ® T100 GE Healthcare, Orsay, France). One substance, the ligand, is attached on the surface of a sensor chip. The second product, the analyte, is then pumped across the surface via a microfluidic system. If interaction between the ligand and the analyte occurs, the refractive index at the surface of the chip changes and is registered "on line" as an increase in signal.
Mucin isolation
The isolation of transmembrane mucin from cultured HCLE cells has been previously described. 6 Briefly, mucin was purified from stratified HCLE cultures by gel chromatography on a Sepharose CL-4B size exclusion column. The void volume containing the mucin fraction was digested with RNase A and DNase I and further purified by isopycnic density gradient centrifugation in cesium chloride.
Mucin immobilization
In a preliminary step, the transmembrane ocular mucin isolates were immobilized on the Sia Kit Au chips (Biacore ® ) by incubation of the chip surface with 50 µL of the transmembrane mucin solution isolated as described above (80 µg/mL) overnight at room temperature.
Afterwards, the chips were intensively rinsed in MilliQ ® water. Once each chip was prepared and inserted on the Biacore ® T100 apparatus, it was again extensively washed with MilliQ ® water at 30 µL/min for 12 h. Resonance units (RU) were measured before and after the immobilization step to monitor the amount of mucin attached to the Au chips. Calculations of immobilized mucin amounts were performed on the basis of the Biacore ® standards where 1 RU = 1 pg/mm 2 . The optical mucin layer was calculated considering that 1 RU corresponds to a resonance angle shift of 10 -4 degrees. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Binding experiments Binding experiments were performed by flowing saline solutions of G1, G2, and G3 of C-Si anionic and cationic dendrimers (5 or10 µM) over the mucin coated sensor chip surface within the Biacore ® T100 apparatus for 300 s at 10 µL/min. After this contact step, the sensorgram (RU versus time) was collected until equilibrium was reached using physiological saline solution as the running medium control. All studies were performed in triplicate at 35ºC, the physiological ocular surface temperature.
14 Results were statistically analyzed by one-way analysis of variance (ANOVA) using SPSS version 16.0 software. Post-ANOVA analyses were carried out according to the Bonferroni's multiple comparisons test. Results were considered significant when p<0.05.
Efficacy studies Acetazolamide formulations: Preparation and characterization
Acetazolamide formulations were prepared according to the following procedures: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Determinations were performed at 33-35°C in triplicate. For all of the preparations tested, the instillation volume was 25 µL. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Differences in the efficacy treatment between F1 and F2 were considered significant when the two-sided 95% confidence interval for the difference between the means of the selected parameters excluded zero.
14
Results
Carbosilane dendrimers
Formation of cationic carbosilane dendrimers with -NH 3 + moieties at the periphery can be achieved by protonation of neutral primary amine dendrimers. 7, 10 However, the synthesis of these amine derivatives requires harsh reaction conditions, and the amine dendrimers also have a high aggregation tendency, making storage and manipulation difficult. Furthermore, allylamine is a highly toxic and volatile liquid.
For that reason, we used a different approach to obtain cationic carbosilane dendrimers.
First, neutral dendrimers were prepared with primary amino groups protected with Boc, (Scheme 1). These compounds were obtained by a simple hydrosilylation reaction of commercially available C 3 H 5 NHBoc. This material is a solid that is clearly lesser toxic than allylamine, and it has dendrimers that can be decorated with Si-H terminal bonds following a procedure similar to that described for related carbosilane dendrons. 15 The neutral dendrimers thus obtained can be easily stored even in the absence of solvents. NMR spectroscopy showed the disappearance of resonances corresponding to the starting SiMe 2 H functions and the presence of the new groups. The new alkyl chainformed Si(CH 2 ) 3 N was detected by TOCSY-NMR spectroscopy, observing the three methylene groups as multiplets at about 3.0 ppm (CH 2 N), 1.4 (internal CH 2 ), and 0.5 (CH 2 Si). By 13 C NMR spectroscopy, 13 C was found at about 44 ppm. Also, the carbonyl carbon atom was present at about 156 ppm. Finally, in the 29 Si NMR spectra, the outermost silicon atom was present at about 2.3 ppm, whereas the initial SiH resonance was observed at about -14 ppm. G2-C and G3-C in this paper) (Scheme 1). These derivatives appeared as white solids that were soluble in water, DMSO, and MeOH. In these compounds, the main NMR resonance belonged to the CH 2 N groups, observed at about 2.80 ppm in the 1 H NMR spectra and at about 48.0 ppm in the 13 C NMR spectra. The final structures are presented in Figure 1 . The exposure of HCLE and IOBA-NHC cultures to the anionic and cationic C-Si dendrimers for 15 minutes was intended to mimic a single drop administration to the ocular surface. Exposures for 1 and 4 h were designed to simulate repeated exposures to the ocular surface. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 carbosilane cationic dendrimers, G3-C, it was necessary to reduce the concentration to 5 µM to obtain non-toxic solutions.
In vitro tolerance studies
In vivo tolerance studies
At 5 and 10 µM, the evaluated carbosilane dendrimer solutions presented neither discomfort nor abnormal clinical signs after topical administration in rabbit eyes ( Table 1 ). The Efron scale scores ranged from 0 -2 in all cases. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 The carbosilane dendrimer concentrations used to assess the interaction between the dendrimers and transmembrane ocular mucins were the same as used in the in vivo tolerance studies. In these experiments, the behaviors of the anionic and cationic dendrimers in contact with ocular mucin were completely different from one another. The sensorgram values for the anionic dendrimers returned to almost zero after about 350 s, indicating that the interaction between the dendrimers and mucin was nonpermanent ( Figure 3a) . In contrast, a significant portion of the cationic dendrimers in contact with the ocular mucin layer was retained in the glycoprotein layer, permanently modifying the RU signal ( Figure   3b ). The highest retention was observed for 5 µM G3-C. 
Formulation characterization: pH, surface tension, and osmolarity
Based upon the mucoadhesion studies, the most promising candidate dendrimer was 5 µM G3-C, which we then used to prepare the ACZ formulation (drug:polymer ratio 3149:1). The pH, surface tension, and osmolarity of the ACZ solution in physiological saline media (0.9%), with and without dendrimers (F2 and F1 respectively), were determined (Table 2) . The pH of both F1 and F2 was 5.6±0.1 ( Table 2 ). The osmolarity of the F1 formulation was 294.5±1.5 mOsm, which was not significantly different from the F2 osmolarity ( Table 2 ). The surface tension of F2 was significantly lower than F1 (p < 0.05), reflecting moderate tensioactive behavior for G3-C dendrimers. 
Intraocular pressure
Several activity parameters were selected to evaluate the effect of 5 µM G3-C dendrimer on the ACZ-induced hypotension: onset time, peak effect time, maximal IOP reduction (∆IOP max ), effective time period, and area under the IOP% versus time curve (AUC 0 8h ). Neither 0.9% saline (Figure 4a ) nor 0.9% saline with 5 µM G3-C dendrimer (Figure 4b) , both of which served as ACZ-free controls, had a hypotensive effect. For F1, composed of 0.07% ACZ in 0.9% saline, the onset of hypotension was evident at 2 h post-instillation and lasted for four hours (p < 0.05, Figure 4a ). For F2, composed of 0.07% ACZ in 0.9% saline containing 5 µM G3-C dendrimer, the hypotensive onset was evident at 1 h post-instillation and lasted for 7 hours (p < 0.05, Figure 4b) . Furthermore, the presence of the dendrimer in the formulation slightly delayed the maximal ∆IOP effect.
The maximum hypotensive effect, 22.6%, was reached by F2, and it was significantly greater than the value achieved by F1, 17.2% (p = 0.0057, Figure 4c ). The AUC 0 8h of F1, 72.8% h, was lower than that for F2 (p = 0.0137, Figure 4d ). The efficacy of the formulations, as measured by the confidence intervals of the AUC 0 8h and the ∆IOP max , was significantly higher for F2 than F1 ( Figure 5 ). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 ophthalmology. Vandamme and Brobeck demonstrated that the co-administration of PAMAM dendrimers with pilocarpine or tropicamide prolonged and sustained the pharmacological effect of the drugs in comparison to classical drug solutions. 4 More recently, using surface biosensors we demonstrated a strong interaction between PAMAM dendrimers and ocular transmembrane mucins. 6 According to these initial works, it is worth considering dendrimers as useful tools to increase drug retention time on the ocular surface, which in turn could reduce the administration frequency and thus increase patient compliance.
With this idea, we generated new dendrimers based on a carbosilane structure, and evaluated the suitability as eyedrop excipients. The carbosilane skeleton provides these dendrimers with unique advantages. Among them, a simple method for synthesis, chemical inertia of the carbon-carbon and carbon-silicon bonds that prevent secondary reactions, and importantly, a highly hydrophobic character that allows better interaction of the dendrimer with biological membranes and/or hydrophobic drugs.
Because this was the first time that these structures have been evaluated for ocular administration, we performed tolerance studies to determine the suitable concentration for ocular tissues. The initial in vitro tolerance assay with human ocular cell lines showed higher toxicity for the cationic dendrimers than for the anionic ones. These results are in concordance with other cytotoxicity studies performed in different cell lines. 22, 23 Some authors have attributed the cytotoxicity of cationic dendrimers to the high density of positive charges that increases with each generation of dendrimer and that could disrupt the cell membranes. [24] [25] [26] Nevertheless, several studies have demonstrated that cationic dendrimers have the same or lower toxicity than polycationic linear polymers. [26] [27] [28] Indeed, Vandamme and Brobeck, for example, observed better tolerance results for PAMAM dendrimers than for linear polymers (hydroxypropylmethyl cellulose and Carbopol ® ) on the ocular surface. 4 Furthermore, Bermejo and co-workers evaluated the biocompatibility of carbosilane dendrimers in primary cell cultures of peripheral blood mononuclear cells and erythrocytes and found they had good toxicity profiles over extended periods of time. 7 Based upon our in vitro tolerance studies, we administered anionic and cationic carbosilane dendrimer solutions to the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 ocular surface of rabbit eyes and found no alterations or discomfort. This further confirmed that the polymer concentrations selected in the in vitro study were suitable for ocular administration in animals.
We next determined the possible interaction of carbosilane dendrimers with elements of the ocular surface, specifically with corneal transmembrane mucins. These high molecular weight glycoproteins cover the corneal and conjunctival epithelia, anchor the precorneal tear film, and play an essential role in mucoadhesion. 29 We used surface biosensors with high sensitivity, so only small amounts of ligand and analyte were needed. [30] [31] [32] Because this is the first in vitro method specifically designed to evaluate interfacial mucin-polymer interactions, we recently proposed it as a very valuable tool in understanding the interactions of ocular transmembrane mucins with polymers or other macromolecules, especially when low amounts of mucins are available. 6 The cationic dendrimer G3-C exhibited a significant permanent chemical adherence to the ocular transmembrane mucins. This interaction might be governed by electrostatic interactions between primary amino groups of the dendrimers and the sialic acid and sulphated groups present in the glycosylated chains of the mucins. In a previous work, this technique showed that the anionic dendrimer PAMAM-COOH permanently interacted with the ocular mucin layer, probably due to the formation of hydrogen bonds between charged carboxylic groups of the dendrimer and the sugar residue on the mucins side chains. 6 However, the anionic carbosilane dendrimers used in the current work had a more hydrophobic backbone and non-protonated terminal carboxylate groups compared to PAMAM. Thus the formation of such interactions between the anionic carbosilane dendrimers and the mucins was not favored, probably because the electrostatic repulsion with the negatively charged mucin surface was strong enough to prevent permanent chemical interaction. Due to the lack of mucin interaction, we chose not to pursue the anionic dendrimers in further studies.
ACZ was chosen as the model drug to evaluate the potential of enhancing ocular surface bioavailability. This carbonic anhydrase inhibitor has a potent specific effect in reducing aqueous humor 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 production, and therefore, intraocular pressure. It has high potential in the treatment of glaucoma, in which high and persistent IOP promotes damage of the optic disk at the juncture of the optic nerve and retina, provoking irreversible retinal degeneration and blindness. However, the use of ACZ is limited because it has low bioavailability after ocular instillation due to low aqueous solubility and limited ocular penetration. For those same reasons, ACZ has gained attention as a model drug to test different strategies to increase bioavailability after ophthalmic application. Some efforts have been explored with this model drug, from the classical approach of using drug suspensions in polymeric solutions 33 to the use of more structured and sophisticated systems such as liposomes, 34 cyclodextrin complexes, 35, 36 niosomes, 37 nanoparticles, 38 and commercial poly(propyleneimine) dendrimers. 39 In those studies, ACZ efficacy was improved; however in some cases, tolerance studies were either not performed or they were unsuitable.
Consequently, the potential cytotoxicity of the formulations is unknown.
In this work, we performed the essential in vitro and in vivo tolerance studies that allowed us to select an innocuous final prototype for in vivo efficacy studies. pH and osmolarity studies confirmed that the behavior of the selected formulation is totally compatible with the ocular surface. 40 The very simplistic approach explored takes advantage of the high interaction of cationic carbosilane dendrimers with ocular transmembrane mucins as well as the tensioactive behavior observed for these polymers. The inclusion of a very low amount of cationic carbosilane dendrimer, 5 µM G3-C, in the ACZ solution in saline media resulted in a more rapid and extended hypotensive effect, leading to a significant increment in the efficacy. The low drug:polymer ratio used in this formulation indicates that most of the drug must not be directly attached to the dendrimer structure. Under these conditions, the inclusion of the cationic carbosilane dendrimers might promote the formation of a well-spread aqueous eyedrop layer, favored by the tensioactive nature of the formulation, that is strongly attached to the ocular surface and that enhances the retention of the drug. In contrast to formulations containing linear polymers, this increment in the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 retention time would be achieved without modifying the viscosity of the tear film, preventing the discomfort typically associated to these viscous media.
29
Conclusions
The high chemical versatility and the small and controlled size of dendrimers allow the design of preparations able to interact with biological molecules, representing a simplified alternative to more complex systems for drug administration. In this work, we evaluated the potential use of ionic C-Si dendrimers for ocular administration. In vitro and in vivo tolerance studies were performed to select an innocuous prototype.
In this proof of concept, the inclusion of only a very low amount of cationic carbosilane dendrimer was well tolerated and improved the hypotensive effect of an ACZ solution by decreasing the onset time and increasing the duration after a single instillation. This is the first work demonstrating that carbosilane dendrimers can enhance the bioavailability of drugs administered topically in the eye . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Fund. Dr. Arguëso thanks the US National Institutes of Health for financial support through the National Eye Institute Grant No. R01EY014847 (PA).
Notes and references
Electronic Supplementary Information (ESI) available: Drawing and NMR spectra of compounds described in the paper. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47 !"#$%&#'(")%% *+,-%.%/,0%123% !"#$%&#'(")% 45,4%.%/,-%123% !"#$%&#'(")%% 6*,+%.%6,+%1% !"#$%&#'(")% ++,7%.%6,6%1% )*+' ),+' 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47 
